All News
What is the Future of MTX for Psoriatic Arthritis?
Like most rheumatologists, I retain a deep and abiding love for methotrexate.
Read ArticleAutoimmunity in the Setting of Primary Immunodeficiency
There are many avenues for interdisciplinary collaboration within rheumatology, as our specialty encompasses every organ system and diseases with protean manifestations.
Read ArticleACR 2018 Podcast - Day 2B
Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTE
Read ArticleACR 2018 - Day 2 Report
Monday was a packed day of sessions and studies. Here are our just a few of our highlights.
Read ArticleACR 2018 Podcast - Day 1B
Audio Highlights and Interviews from Day 1 at the ACR 2018 meeting - LISTEN HERE
Read Article
ACR 2018 Podcast - Day 2A
Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTEN HERE
Read Article
Technology Tools for the Rheumatologist
Four years ago, the genesis of this session (technology tools for rheumatologists) was from the frustration of the archaic technologies we have been using in our medical practices (including user hostile EHRs), compared to the rapid advancing pace of the consumer technologies we use at home. So came the struggle to adapt affordable and usable consumer technology products in the office that would save time (or at least be time neutral) and impact patient management.
Read ArticleIs DAS28 and HAQ-DI Headed for the Graveyard?
Dr. Joseph Smolen delivered one of the most elegant and informative talk on rheumatoid arthritis at this ACR’s meeting as a tribute to Dr. Paul Klemperer. Dr. Smolen led us on a journey, and had us feeling content with what we are doing in practice as we walked with him from historical discoveries of RA through new drug development. Then Dr. Smolen did the unthinkable: he made us crash!
Read ArticleACR 2018 Podcast - Day 1A
Check out the first part of our Day 1 Podcast from ACR 2018 - LISTEN HERE
Read ArticleBrittany A MissbeeMD ( View Tweet)
Nicole Bitencourt NicoleBitencou5 ( View Tweet)
Philip Gardiner PhilipGardiner ( View Tweet)